Otenabant

Clinical data
ATC code	none
Identifiers
IUPAC name 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4- carboxamide
CAS Number	686344-29-6 Y
PubChemCID	10052040
ChemSpider	8227602 N
UNII	J8211Y53EF
KEGG	D09362 Y
ChEMBL	ChEMBL562668 N
CompTox Dashboard(EPA)	DTXSID20988316
Chemical and physical data
Formula	C25H25Cl2N7O
Molar mass	510.42 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N
InChI InChI=1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35) N Key:UNAZAADNBYXMIV-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Otenabant (CP-945,598) is a drug that acts as a potent and highly selectiveCB₁antagonist.^[1] It was developed byPfizer for the treatment ofobesity,^[2] but development for this application has been discontinued following the problems seen during clinical use of the similar drugrimonabant.^[3]

• Cannabinoid receptor antagonist

Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Drugs not assigned an ATC code
• Cannabinoids
• Purines
• Piperidines
• Carboxamides
• Drugs developed by Pfizer
• CB1 receptor antagonists
• 2-Chlorophenyl compounds
• 4-Chlorophenyl compounds
• Cannabinoid stubs

• CS1: long volume value
• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Articles with changed ChemSpider identifier
• Articles with changed EBI identifier
• Articles with changed InChI identifier
• Chemical pages without DrugBank identifier
• Drugs with no legal status
• Drugboxes which contain changes to verified fields
• Drugboxes which contain changes to watched fields
• All stub articles